font size
Sign inprintPrint

CAPITAL MARKETS:

AbbVie Terminates Shire Acquisition, But M&A Activity Remains Brisk

Total life sciences transactions through first 10 months of 2014 reach $253.3 Billion, says Burrill Media


New tax rules from the U.S. Department of the Treasury intended to discourage so-called inversions to avoid U.S. taxation led to the termination of AbbVie’s planned $54.7 billion acquisition of Shire, but it did little to slow the robust M&A activity that has characterized the current year, Burrill Media reported. Read More
Other recent stories


Follow burrillreport on Twitter